Adverse Drug Reaction Reporting in Bangladesh: Current Scenario, Barriers, and Strategies for Improvement

Background

Adverse Drug Reactions (ADRs) are a major cause of morbidity, mortality, and increased healthcare costs worldwide. Pharmacovigilance systems play a crucial role in ensuring medication safety; however, ADR reporting remains inadequate in many developing countries, including Bangladesh.

Objectives

This study aimed to assess physicians’ knowledge, awareness, attitudes, and practices regarding ADR reporting in Bangladesh and to identify barriers and possible strategies to improve spontaneous reporting.

Materials and Methods

A cross-sectional observational study was conducted between December 2018 and March 2019 among 50 physicians working in different hospitals. Data were collected using a predesigned structured questionnaire assessing knowledge, awareness, practices, attitudes, and perceived barriers related to ADR reporting. Data were analyzed descriptively and expressed as percentages.

Results

Although most physicians perceived ADR reporting as a necessary and professional obligation, only a small proportion had ever reported an ADR. Major barriers included a lack of knowledge regarding reporting procedures, unavailability of reporting forms, lack of time, and insufficient clinical confidence. Most physicians supported compulsory ADR reporting.

Conclusion

Despite positive attitudes toward ADR reporting, awareness, and actual reporting practices among physicians in Bangladesh remain inadequate. Strengthening training programs, simplifying reporting systems, and increasing institutional and governmental support are urgently needed to enhance pharmacovigilance and patient safety.